ليست عنوان مقالات لاتين Prospects of Utilizing Insects as Alternative Sources of Protein in Poultry Diets in Botswana: a Review Protection of the environment by using innovative greening technologies in land transport

<< مقالات لاتين >>

<< بر اساس عنوان >>

1

Prospects of Utilizing Insects as Alternative Sources of Protein in Poultry Diets in Botswana: a Review

2

Prospects of UV radiation for application in postharvest technology

3

Prospects of whole grain crops of wheat, rye and triticale under different fertilizer regimes for energy production

4

Prospects of wind energy in Bangladesh

5

Prospects of wind energy sector development in Serbia with relevant regulatory framework overview

6

Prospects of wind farm development in Algeria Original Research Article

7

Prospects of wind farm development in Saudi Arabia

8

Prospects of wind power plants in Libya: a case study

9

Prospects with renal artery stenting

10

Prospects, problems, and prerequisites for national health examination surveys in developing countries

11

Prospects: Opening the space for new perspectives and debates

12

Prospectus of mobile TV: Another bubble or killer application?

13

Prosper Ménière

14

Prosperetti, A., Tryggvason, G. Computational methods for multiphase flows, Cambridge University Press, 481 pp., 95$ (hardback)

15

Prospering in a transition economy through information technology-supported organizational learning

16

Prospering in a world of everincreasing global competitiveness: A British industrialistʹs view

17

Prospering in the New Markets: Ten Key Second-Generation ISO Issues

18

Prosperity Without Growth: Economics for a Finite Planet, Tim Jackson. Earthscan (2011). xii+276 pp., $17.00, ISBN: 978-1-84971-323-8, paperback

19

Prosperity without Growth: Economics for a Finite Planet, Tim Jackson. Earthscan, London (2009)

20

Prosperity without Growth: Economics for a Finite Planet, Tim Jackson. Earthscan. Hardcover, London (2009)

21

Prospero Lambertini: miraculous cure of epilepsy and canonization of Vatican saints

22

Prospero-related homeobox 1 (PROX1) is frequently inactivated by genomic deletions and epigenetic silencing in carcinomas of the bilary system

23

PROST: A Parabolic Reconstruction of Surface Tension for the Volume-of-Fluid Method

24

Prostacyclin and thromboxane levels in pleural space fluid during cardiopulmonary bypass

25

Prostacyclin attenuates oxidative damage of myocytes via stimulation of EP3 receptor

26

Prostacyclin Reduces Incidence of Myocardial Damage After Coronary Endarterectomy

27

Prostacyclin synthase gene transfer inhibits neointimal formation by suppressing PPARδ expression

28

Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia

29

Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia

30

Prostaglandin A2 influences gene expression in an established insect cell line (BCIRL-HzAM1) cells

31

Prostaglandin D2 and sleep regulation

32

Prostaglandin D2 Synthase Secreted in the Caput Epididymidis Displays Spatial and Temporal Delay Between Messenger RNA and Protein Expression During Postnatal Development

33

Prostaglandin E and 12-O-Tetradecanoylphorbol-13-acetate Are Negative Modulators of Retinoic Acid Synthesis

34

Prostaglandin E and F Receptor Expression and Myometrial Sensitivity at Labor Onset in the Sheep

35

Prostaglandin E receptor 4 (PTGER4) involved in host protection against immune challenge in oyster, Crassostrea hongkongensis

36

Prostaglandin E1 (PGE1) reduces cardiac-derived TXA2 release in ischaemic arrest in isolated working rat heart

37

Prostaglandin E1 Combined with Chitosan Conduit Improves Sciatic Nerve Regeneration in Rats

38

Prostaglandin E1 From the Tip of an Intraaortic Balloon Catheter for Lower Limb Ischemia

39

Prostaglandin E1 induces vascular endothelial growth factor-1 in human adult cardiac myocytes but not in human adult cardiac fibroblasts via a cAMP-dependent mechanism

40

Prostaglandin E1 versus steroid in combination with hyperbaric oxygen therapy for idiopathic sudden sensorineural hearing loss

41

Prostaglandin E1-initiated immune regulation during human mixed lymphocyte reaction

42

Prostaglandin E2 activates Src signaling in lung adenocarcinoma cell via EP3

43

Prostaglandin E2 affects osteoblast biology in a dose-dependent manner: An in vitro study

44

Prostaglandin E2 and aspirin-induced asthma

45

Prostaglandin E2 and Stem Cell Factor Can Deliver Opposing Signals to B Lymphocyte Precursors

46

Prostaglandin E2 concentrations and sperm motility in fractionated stallion ejaculates

47

Prostaglandin E2 down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor

48

Prostaglandin E2 down-regulates the expression of CD25 on bovine T cells, and this effect is mediated through the EP4 receptor

49

Prostaglandin E2 Enhancement of Interferon-γ Production by Antigen-Stimulated Type 1 Helper T Cells

50

Prostaglandin E2 enhances alveolar bone formation in the rat mandible

51

Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation

52

Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation

53

Prostaglandin E2 for cervical ripening: A randomized comparison of Cervidil versus Prepidil, ,

54

Prostaglandin E2 in Soluble Factor-Mediated Immune Suppression by First Trimester Decidual Cells

55

Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia

56

Prostaglandin E2 induces c-fos mRNA expression in the osteoblastic cell line MC3T3-E1 using the serum responsive element

57

Prostaglandin E2 Inhibits B Lymphocyte Activation by a cAMP-Dependent Mechanism: PGE-Inducible Regulatory Proteins

58

Prostaglandin E2 inhibits mineralization and enhances matrix metalloproteinase-13 in mature cementoblasts mainly via the EP4 pathway

59

Prostaglandin E2 inhibits replication of HIV-1 in macrophages through activation of protein kinase A

60

Prostaglandin E2 inhibits TNF production in murine bone marrow-derived dendritic cells

61

Prostaglandin E2 inhibits transforming growth factor β1-mediated induction of collagen α1(I) in hepatic stellate cells

62

Prostaglandin E2 levels in human brain tumor tissues and arachidonic acid levels in the plasma membrane of human brain tumors

63

Prostaglandin E2 modulates proximal tubule Na+-ATPase activity: Cooperative effect between protein kinase A and protein kinase C

64

Prostaglandin E2 promotes colorectal adenoma growth via transactivation of the nuclear peroxisome proliferator-activated receptor δ

65

Prostaglandin E2 promotes the induction of anergy during T helper cell recognition of myelin basic protein

66

Prostaglandin E2 receptor (EP4) selective agonist (ONO-4819.CD) accelerates bone repair of femoral cortex after drill-hole injury associated with local upregulation of bone turnover in mature rats

67

Prostaglandin E2 regulates both interleukin-2 and granulocyte- macrophage colony-stimulating factor gene expression in bovine lymphocytes

68

Prostaglandin E2 suppresses β1-integrin expression via E-prostanoid receptor in human monocytes/macrophages

69

Prostaglandin E2 synthesis and secretion: The role of PGE2 synthases

70

Prostaglandin E2and IL-4 Provide Naive CD4+T Cells with Distinct Inhibitory Signals for the Priming of IFN-γ Production

71

Prostaglandin E2-bisphosphonate conjugates: potential agents for treatment of osteoporosis Original Research Article

72

Prostaglandin E2Induction of Binding Activity to CRE and AP-2 Elements in Human T Lymphocytes

73

Prostaglandin E2Inhibits the Interleukin-2 Promoter Activity through Down-Regulation of the Oct-Dependent Transcription of the Octamer Motif

74

Prostaglandin E2Inhibits the Nuclear Transcription of the Human Interleukin 2, but Not the IL-4, Gene in Human T Cells by Targeting Transcription Factors AP-1 and NF-AT

75

Prostaglandin E3 metabolism and cancer

76

Prostaglandin endoperoxide H synthase type 1 and type 2 messenger ribonucleic acid in human fetal tissues throughout gestation and in the newborn infant

77

PROSTAGLANDIN F2 ALPHA: AN EFFECTIVE ALTERNATE TO SURGICAL CONTROL OF POSTPARTUM HEMORRHAGE IN UTERINE ATONY

78

Prostaglandin F2(alpha) regulates distinct physiological changes in early and mid-cycle bovine corpora lutea

79

Prostaglandin F2(alpha)-induced luteolysis of aging corpora lutea in hysterectomized pigs

80

Prostaglandin F2alpha concentrations in stallion semen and the effect of 24 hours of cold storage on exogenous prostaglandin F2alpha concentrations

81

Prostaglandin F2α increases the sensitivity of the contractile proteins to Ca2+ in human myometrium

82

Prostaglandin F2α output by amnion-chorion-decidua: Relationship with labor and prostaglandin E2 concentration at the amniotic surface

83

Prostaglandin F2α rises in response to hydroxyl radical generated in vivo

84

Prostaglandin F-2α Stimulates The Secretion of Vascular Endothelial Growth Factor and Induces Cell Proliferation and Migration of Adipose Tissue Derived Mesenchymal Stem Cells

85

Prostaglandin F2α supplemented semen improves reproductive performance in artificially inseminated sows

86

Prostaglandin F2α-induced Ca++ oscillations in human myometrial cells and the role of RU 486

87

Prostaglandin G/H Synthase Isoenzyme 2 Expression in Fibroblasts - Regulation by Dexamethasone, Mitogens, and Oncogenes

88

Prostaglandin G/H Synthase Isoenzyme 2 Expression in Fibroblasts - Regulation by Dexamethasone, Mitogens, and Oncogenes

89

Prostaglandin G/H synthase-2 (cyclooxygenase-2) mRNA expression is decreased in Alzheimerʹs disease

90

Prostaglandin H synthase Type 2 is differentially expressed in endometrium based on pregnancy status in pony mares and responds to oxytocin and conceptus secretions in explant culture

91

Prostaglandin H synthase: Resolved and unresolved mechanistic issues

92

Prostaglandin H Synthase-1: Evaluation of C-Terminus Function

93

Prostaglandin H Synthase-2 Is Induced in Syrian Hamster Embryo Cells in Response to Basic Fibroblast Growth Factor

94

Prostaglandin H synthase-mediated oxidation and binding to DNA of a detoxication metabolite of carcinogenic Sudan I, 1-(phenylazo)-2,6-dihydroxynaphthalene

95

Prostaglandin inhibitors in preterm labour

96

Prostaglandin J2 Inhibition of Mesangial Cell iNOS Expression

97

Prostaglandin J2 Inhibition of Mesangial Cell iNOS Expression

98

Prostaglandin receptors (EP2 and EP4) and angiotensin receptor (AGTR2) mRNA expression increases in the oviducts of Nelore cows submitted to ovarian superstimulation

99

Prostaglandin regulation of fetal plasma adrenocorticotropin and cortisol concentrations in late-gestation sheep

100

Prostaglandin Synthase 2 Expression in Epidermal Growth Factor-Dependent Proliferation of Mouse Keratinocytes

101

Prostaglandin Synthase 2/Cyclooxygenase 2 Gene Polymorphisms and Susceptibility to Urothelial Bladder Cancer in an Iranian Population

102

Prostaglandin treatment at the onset of norgestomet and estradiol-based synchronization protocols did not alter the ovarian follicular dynamics or pregnancy per timed artificial insemination in cyclic Bos indicus heifers

103

Prostaglandin-dependent activation of ERK mediates cell proliferation induced by transforming growth factor β in mouse osteoblastic cells

104

Prostaglandin–E2Regulation of Tumor Necrosis Factor Receptor Release in Human Monocytic THP-1 Cells

105

Prostaglanding E1 or prostacyclin in euro-collins solution fails to improve lung preservation

106

Prostaglandin-induced activation of uterine contractility in pregnant rats does not involve potassium channels

107

Prostaglandins and Cytokines in Pregnancy and Labor

108

Prostaglandins and Nitric Oxide Mediate Superoxide-induced Myocardial Contractile Dysfunction in Isolated Rat Hearts

109

Prostaglandins and reproduction in female farm animals

110

Prostaglandins and the colon cancer connection

111

Prostaglandins as modulators of immunity

112

Prostaglandins for first-trimester termination

113

Prostaglandins for induction of second-trimester termination and intrauterine death

114

Prostaglandins in the prevention and management of postpartum haemorrhage

115

Prostaglandins Mediate Suppression of Lymphocyte Proliferation and Cytokine Synthesis in AcuteTrypanosoma cruziInfection

116

Prostaglandins mediate the effects of 1,25-(OH)2D3 and 24,25-(OH)2D3 on growth plate chondrocytes in a metabolite-specific and cell maturation-dependent manner

117

Prostaglandins Regulate Melanoma-Induced Cytokine Production in Macrophages

118

Prostaglandins, leukotrienes and other eicosanoids — from biogenesis to clinical application, Edited by. F. Marks and G. Furstenberger, Wiley-VCH, Weinheim, 1999. xx+388 pp. ISBN 3-527-29360-4; £ 85.00

119

Prostanoid and isoprostanoid pathways in atherogenesis

120

Prostanoid excretion in incipient singleton and twin pregnancies

121

PROSTANOID-MEDIATED SIGNALLING IN ENDOTHELIUM AND OSTEOBLASTS: EFFECTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR (VEGFR) BLOCKADE

122

Prostanoids and pain: unraveling mechanisms and revealing therapeutic targets

123

Prostanoids do not affect endothelium-dependent vasodilation in healthy humans

124

Prostanoids regulate the coronary circulation in aged rat heart stimulated by urotensin II

125

Prostase/KLK-L1 is differentially expressed in normal/benign versus malignant ovarian tissues

126

Prostasome-Like Particles in Stallion Semen

127

Prostate adenocarcinoma manifesting as generalized lymphadenopathy

128

Prostate adenocarcinoma with negative immunohistochemical stain of prostate-specific antigen presenting with cervical mass: A case report

129

Prostate apoptosis response gene-4 (par-4) abrogates the survival function of p185BCR-ABL in hematopoietic cells

130

Prostate biopsy and what men should be told about the procedure

131

Prostate biopsy in patients with long-term use of indwelling bladder catheter: What is the rationale?

132

Prostate Biopsy Using Transrectal Ultrasonography; The Optimal Number of Cores Regarding Cancer Detection Rate and Complications

133

Prostate boundary segmentation from 2D ultrasound images

134

Prostate brachytherapy in obese patients

135

Prostate brachytherapy postimplant dosimetry: A comparison of suture-embedded and loose seed implants

136

Prostate brachytherapy seed migration and dosimetry: analysis of stranded sources and other potential predictive factors

137

Prostate brachytherapy seed migration to the right coronary artery associated with an acute myocardial infarction

138

Prostate brachytherapy under local anesthesia: lessons from the first 600 patients

139

Prostate cancer

140

Prostate cancer

141

Prostate cancer

142

Prostate cancer

143

Prostate cancer and computer models: Background, limitations, and potential

144

Prostate Cancer and Quality of Life in the Elderly: A Literature Review

145

Prostate Cancer Antigen 3 Gene Expression in Peripheral Blood and Urine Sediments from Prostate Cancer and Benign Prostatic Hyperplasia Patients versus Healthy Individuals

146

Prostate cancer around the world. An overview

147

Prostate cancer as a multifactorial disorder; an overview of different sides of disease

148

Prostate cancer biomarkers: An update

149

Prostate cancer cells lose their sensitivity to TGFβI growth inhibition with tumor progression

150

Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo: Gu G, Yuan J, Wills M, Kasper S, Department of Urologic Surgery, Vanderbilt University Medical Center; Department of Pathology, Vanderbilt Children’s Hospi

151

Prostate cancer chemoprevention with 5α-reductase inhibitors

152

Prostate Cancer Detection Rate and the Importance of Premalignant Lesion in Rebiopsy

153

Prostate cancer diagnosis and management

154

Prostate cancer diagnosis: should patients with prostate specific antigen >10 ng/mL have stratified prostate biopsy protocols?

155

Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts

156

Prostate cancer distribution in patients diagnosed by transperineal template-guided saturation biopsy: Implications for brachytherapy treatment planning

157

Prostate cancer epidemiology

158

Prostate cancer gene therapy and the role of radiation

159

Prostate cancer in dogs and men: A unique opportunity to study the disease

160

Prostate cancer in dogs: Comparative and clinical aspects

161

Prostate cancer in the elderly

162

Prostate cancer in the elderly

163

Prostate cancer in the senior men from rural areas in east district of China: Contemporary management and 5-year outcomes at multi-institutional collaboration

164

Prostate cancer incidence rates after removal of incidentally detected cases among lds and non-lds during the era of prostate-specific antigen screening

165

Prostate cancer induces bone metastasis through Wnt-induced bone morphogenetic protein-dependent and independent mechanisms: Dai J, Hall CL, Escara-Wilke J, Mizokami A, Keller JM, Keller ET, Department of Urology, University of Michigan Health System, Ann

166

Prostate cancer mediates osteoclastogenesis through two different pathways

167

Prostate cancer mortality in Connecticut, Iowa and New Mexico African American men

168

Prostate cancer PET bioprobes: Synthesis of [18F]-radiolabeled hydroxyflutamide derivatives Original Research Article

169

Prostate Cancer Predicting Factors A Preliminary Report from Tehran

170

Prostate cancer risk and exposure to ultraviolet radiation: further support for the protective effect of sunlight

171

Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism

172

Prostate cancer risk prediction in a urology clinic in Mexico

173

Prostate cancer risk prediction in a urology clinic in Mexico

174

Prostate cancer risk: Medical history, sexual, and hormonal factors

175

Prostate cancer screening

176

Prostate cancer screening

177

Prostate cancer screening

178

Prostate cancer screening

179

Prostate cancer screening

180

Prostate Cancer Screening and Beliefs about Treatment Efficacy: A National Survey of Primary Care Physicians and Urologists

181

Prostate cancer screening and mortality: Comparison of recent randomized controlled clinical trials

182

Prostate Cancer Screening Behaviors Based on the Health Belief Model in Men Aged 40-70 Years in Fasa City, Fars Province, Iran, in 2019

183

Prostate cancer screening between low-income African-American and Caucasian men☆

184

Prostate Cancer Screening in Greece Current Facts

185

Prostate Cancer Screening in Middle-Aged and Older American Men: Combined Effects of Ethnicity and Years of Schooling

186

Prostate cancer screening perspective, Malaysia

187

Prostate cancer screening strategies with re-screening interval determined by individual baseline prostate-specific antigen values are cost-effective

188

Prostate Cancer Screening Trends of New York State Men at Least 50 Years of Age, 1994 to 1997

189

Prostate cancer screening using prostate specific antigen extracted from dried blood on filter paper

190

Prostate Cancer Screening, Yes or No? the Current Controversy

191

Prostate cancer screening: Clinical applications and challenges☆

192

Prostate Cancer Screening: Yes or No?

193

Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype

194

Prostate Cancer Survival Analysis of 872 Patients in Southern Iran: A Retrospective Cohort Study

195

Prostate cancer survivorship: Lessons from caring for the uninsured

196

Prostate cancer susceptibility is mediated by interactions between exposure to ultraviolet radiation and polymorphisms in the 5′ haplotype block of the vitamin D receptor gene

197

Prostate Cancer with Intraluminal Inclusions: the Association of the Immunophenotype with Grade Score

198

Prostate cancer, masculinity and food. Rationales for perceived diet change

199

Prostate Cancer: Beta Control Your Hormones

200

Prostate Cancer: Current Treatment and Prevention Strategies

201

Prostate cancer: Evidence-based indications for postoperative radiotherapy

202

Prostate cancer: Molecular approaches for detection and prognosis, and angiogenic therapeutic targets

203

Prostate cancer: progression of prostate-specific antigen after external beam irradiation

204

Prostate Cancer: What About Reproducibility of Decision Made at Multidisciplinary Team Management?

205

Prostate carcinoma spatial distribution patterns in Chinese men investigated with systematic transperineal ultrasound guided 11-region biopsy

206

Prostate derived ETS factor (PDEF): A putative tumor metastasis suppressor

207

Prostate gland motion and deformation caused by needle placement during brachytherapy

208

Prostate Helical Tomotherapy: A semi-empirical estimation of the scaling factor based on 2D approximating field

209

Prostate high-dose-rate brachytherapy as salvage treatment of local failure after previous external or permanent seed irradiation for prostate cancer

210

Prostate IMRT: Two-dimensional model of rectal NTCP employing the variability of rectal motion and rectum wall thickness

211

Prostate inflammation. Association with benign prostatic hyperplasia and prostate cancer

212

Prostate Osteoblast-Like Cells: A Reliable Prognostic Marker of Bone Metastasis in Prostate Cancer Patients

213

Prostate Segmentation and Lesions Classification in CT Images Using Mask R-CNN

214

Prostate specific antigen decline following the discontinuation of flutamide in patients with stage D2 prostate cancer

215

Prostate specific antigen gene expression in ovarian cancer post-liver transplantation

216

Prostate Specific Antigen Level in Exposure to Sulfur Mustard

217

Prostate Specific Antigen Levels Among Men With Prostate Cancer in Ramadi City

218

Prostate specific antigen levels in pre-dialysis chronic kidney disease patients

219

Prostate Specific Antigen Nadir After Radical Cystoprostatectomy in Patients with Benign Prostatic Tissue: A Benchmark to Define Biochemical Recurrence After Radical Prostatectomy

220

Prostate Specific Antigen Production by Breast Tumors After Induction with Oral Contraceptives

221

Prostate specific antigen screening for prostate cancer: Knowledge of, attitudes towards, and utilization among primary care physicians

222

Prostate stem cell antigen enhancer and uroplakin II promoter based bladder cancer targeted tissue-specific vector

223

Prostate stem cell antigen: A prospective therapeutic and diagnostic target

224

Prostate tissue retrieval after holmium laser enucleation of the prostate; assessment of non-morcellation approaches

225

Prostate tumor alignment and continuous, real-time adaptive radiation therapy using electromagnetic fiducials: Clinical and cost-utility analyses

226

Prostate tumor antigen gives vaccine hope

227

Prostate tumor progression and prognosis: interplay of tumor and host factors

228

Prostate, breast and gynecological cancer markers RAK with homology to HIV-1

229

Prostate-apoptosis response-4 phosphorylation in vascular smooth muscle

230

Prostatein or Steroid Binding Protein (PSBP) Induces Experimental Autoimmune Prostatitis (EAP) in NOD Mice

231

Prostate-sparing cystectomy: A review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer

232

Prostate-sparing cystectomy: Potential functional advantages and objective oncological risks; a case series and review

233

Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less

234

Prostate-specific antigen (PSA) should drive doing prostate biopsies

235

Prostate-specific antigen (PSA) velocity and benign prostate hypertrophy predict for PSA spikes following prostate brachytherapy

236

Prostate-specific antigen and insulin-like growth factor binding protein-3 in nipple aspirate fluid are associated with breast cancer

237

Prostate-specific antigen and lack of specificity for prostate cells

238

Prostate-specific antigen as a diagnostic marker in female hyperandrogenism

239

Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer

240

Prostate-Specific Antigen Doubling Time as a Predictor of Gleason Grade in Prostate Cancer

241

Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer

242

Prostate-specific antigen for prostate cancer screening: Do physician characteristics affect its use?

243

Prostate-specific antigen found in Type I breast cyst fluids is a secretory product of the apocrine cells lining breast gross cysts

244

Prostate-specific antigen found in Type I breast cyst fluids is a secretory product of the apocrine cells lining breast gross cysts

245

Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies

246

Prostate-specific antigen in black men

247

Prostate-specific antigen in breast disease

248

Prostate-specific antigen in clinical practice

249

Prostate-specific antigen in females: A new tool

250

Prostate-specific antigen in nipple aspirate

251

Prostate-specific antigen kinetics after hypofractionated stereotactic body radiotherapy for localized prostate cancer

252

Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review

253

Prostate-Specific Antigen Levels Among Diabetic Men: Exploring Patients Attending Outpatient Clinic in Yemen

254

Prostate-Specific Antigen Ratio Correlates with Aggressiveness of Histology Grades of Prostate Cancer

255

Prostate-specific antigen relapse-free survival in patients with localized prostate cancer treated by brachytherapy: Joseph J, Al-Qaisieh B, Ash D, Bottomley D, Carey B. Clinical Oncology, Cookridge Hospital, Leeds, West Yorkshire, UK

256

Prostate-specific antigen response after definitive radiotherapy for Skeneʹs gland adenocarcinoma resembling prostate adenocarcinoma

257

Prostate-specific antigen screening of workers under the age of 40 in Japan

258

Prostate-specific antigen test use reported in the 2000 National Health Interview Survey

259

Prostate-specific antigen utilization in Ontario: extent of testing in patients with and without cancer

260

Prostate-specific antigen velocity, and prostate cancer Gleason grade and stage: Pinsky PF, Andriole G, Crawford ED, Chia D, Kramer BS, Grubb R, Greenlee R, Gohagan JK, Division of Cancer Prevention, National Cancer Institute, Bethesda, MD

261

Prostate-specific antigen: An evolving role in diagnosis, monitoring, and treatment evaluation in prostate cancer

262

Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer

263

Prostate-specific membrane antigen expression in the duodenum: implications in coeliac disease and immunotherapy for prostate cancer

264

Prostate-specific membrane antigen in breast carcinoma

265

Prostate-specific membrane antigen-based imaging

266

Prostate-specific membrane antigen-based imaging

267

Prostate-specific membrane antigen-targeted photodynamic therapy induces rapid cytoskeletal disruption

268

Prostatic Abscess MRI Findings: Case Report

269

Prostatic abscess: diagnosis and management in the modern antibiotic era.

270

Prostatic abscess: Objective assessment of the treatment approach in the absence of guidelines

271

Prostatic acid phosphatase in breast cyst fluid

272

Prostatic acid phosphatase predicts cancer-specific survival after Palladium-103 brachytherapy for prostate cancer

273

Prostatic Adenocarcinoma Buccal Metastasis

274

Prostatic Adenocarcinoma Masquerading as Generalized lymphadenopathy and Mimicking lymphoma on FDG PET/CT: Diagnosis, Staging, and Evaluation of Therapy Response by FDG PET/CT

275

Prostatic artery embolization (PAE) for prostatic origin bleeding in the context of prostate malignancy

276

PROSTATIC CANCER - A RETROSPECTIVE STUDY OF 50 PATIENTS

277

Prostatic cancer: Hospital-based prostate specific antigen screening

278

Prostatic capsule- and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients: Botto H, Sebe P, Molinie V, Herve JM, Yonneau L, Lebret T, Department of Urology, Hopital Foch, Suresnes, France

279

Prostatic Carcinoma Shrunk After Intraprostatic Injection of Botulinum Toxin

280

281

Prostatic Cyst Causing Severe Infravesical Obstruction in a Young Patient

282

Prostatic disorders in the dog

283

Prostatic extramedullary leukemia as a first site of relapse of acute nonlymphocytic leukemia

284

Prostatic Fluid Free Insulin-Like Growth Factor-1 in Relation to Benign Prostatic Hyperplasia: A Controlled Study

285

Prostatic Fossa Gauze-Packing in the Prevention of Blood Clot Obstruction of the Bladder after Transvesical Prostatectomy

286

Prostatic Masses in Geldings: Two Cases

287

Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application

288

Prostatic tissue ablation by transrectal high intensity focused ultrasound: histological impact and clinical application

289

Prostatic Zn determination for prostate cancer diagnosis

290

Prostatitis and urinary tract infection in men: what’s new; what’s true?

291

Prostephanus truncatus IN AFRICA: A REVIEW OF BIOLOGICAL TRENDS AND PERSPECTIVES ON FUTURE PEST MANAGEMENT STRATEGIES

292

Prosthesis for Aortic Arch Substitution

293

Prosthesis infection after lung and superior vena cava system resection for non-small cell lung cancer is a life-threatening complication. We report a case in which an intrathoracic muscle flap transposition was used to cure tracheal fistula associated wi

294

Prosthesis-Patient Mismatch After “High-Risk” Aortic Valve Replacement

295

Prosthesis‑Patient Mismatch after Aortic Valve Replacement: A Single‑Center Experience

296

Prosthesis-Patient Mismatch After Aortic Valve Replacement: Impact of Age and Body Size on Late Survival

297

Prosthesis–Patient Mismatch After Transcatheter Aortic Valve Implantation With the Medtronic CoreValve System in Patients With Aortic Stenosis

298

Prosthesis-Patient Mismatch in the Elderly: Survival, Ventricular Mass Regression, and Quality of Life

299

Prosthesis–Patient Mismatch in the Transcatheter Aortic Valve Replacement Era

300

Prosthesis–Patient Mismatch is Not Clinically Relevant in Aortic Valve Replacement Using the Carpentier-Edwards Perimount Valve

301

Prosthetic adaptability: A new concept for shoulder arthroplasty

302

Prosthetic and Surgical Approach for Oral Rehabilitation in a Patient with Amelogenesis Imperfecta: A Clinical Report

303

Prosthetic ankle joint stiffness during weight acceptance in trans-tibial amputees

304

Prosthetic aortic graft cannulation: a simple technique to secure hemostasis

305

Prosthetic aortic heart valves: Modeling and design

306

Prosthetic Bypass with a Distal Vein Patch for Limb Salvage

307

Prosthetic Complications in a Patient with Papillon-Lefevre Syndrome Treated with Dental Implants: A Case Report

308

PROSTHETIC COMPLICATIONS IN IMPLANT SUPPORTED FIXED PROSTHESIS: A FOUR YEAR MULTI-CENTER RETROSPECTIVE ANALYSIS

309

Prosthetic component relationship of the reverse Delta III total shoulder prosthesis in the transverse plane of the body

310

Prosthetic considerations of contemporary all-ceramic fixed partial dentures: a review of the literature

311

Prosthetic Correction of Proclined Maxillary Incisors: A Biomechanical Analysis

312

Prosthetic Failure in Implant Dentistry

313

Prosthetic foot habituation time of a subject with unilateral fibular hemimelia — A pilot study

314

Prosthetic Hand Finger Control Using Fuzzy Sliding Modes

315

Prosthetic heart valve thrombosis: Pathogenesis, diagnosis and management

316

Prosthetic heart valves: Catering for the few

317

Prosthetic Heart Valves: Objective Performance Criteria Versus Randomized Clinical Trial

318

Prosthetic heart valves: Types and echocardiographic evaluation

319

Prosthetic heart valves’ mechanical loading of red blood cells in patients with hereditary membrane defects

320

Prosthetic Joint Infection Trends at a Dedicated OrthopaedicsSpecialty Hospital

321

Prosthetic Joint Infections Due to Coagulase-Negative Staphylococci

322

Prosthetic joint infections: controversies and clues

323

Prosthetic Management of a Child with Hypohidrotic Ectodermal Dysplasia: 6-Year Follow-Up

324

Prosthetic Management of an Extensive Maxillary Alveolar Defect with an Implant-Supported Restoration

325

Prosthetic mitral valve obstruction: diagnosis with real-time threedimensional transesophageal echocardiography

326

Prosthetic mitral valve replacement after atrioventricular septal defect repair: a technique for small children

327

Prosthetic Mitral Valve Replacement: Late Complications After Native Valve Preservation

328

Prosthetic particles modify the expression of bone-related proteins by human osteoblastic cells in vitro

329

PROSTHETIC PROBLEMS OF TRANSTIBIAL AMPUTEE

330

Prosthetic Pulmonary Valve Malfunction

331

Prosthetic radial head components and proximal radial morphology: A mismatch

332

Prosthetic radioiodination of interleukin-8 ([123/131I]-IL-8): biological behavior in a mouse infection model

333

Prosthetic Reconstruction for a Child with a Congenital Bilateral Ear Deformity: Case Report

334

Prosthetic reconstruction of a patient with Amelogenesis imperfecta: A two-year follow up evaluation

335

Prosthetic rectopexy to the pelvic floor and sigmoidectomy for rectal prolapse

336

Prosthetic rehabilitation and treatment outcome of partially edentulous patients with severe tooth wear: 3-Years results

337

Prosthetic rehabilitation and treatment outcome of partially edentulous patients with severe tooth wear: 3-Years results

338

Prosthetic Rehabilitation of a Nasomaxillary Defect Utilizing a two-Component Prosthesis: a Clinical Report

339

Prosthetic rehabilitation of a patient with a palatal fistula and an atrophic mandibular ridge using admix material to record the neutral zone: A case report

340

Prosthetic rehabilitation of a patient with total rhinectomy and partial maxillectomy with magnet-retained oral-nasal combination prosthesis: A case report

341

Prosthetic rehabilitation of an edentulous Veau s class II -A Case report.

342

Prosthetic Rehabilitation of Child Victim of Avulsion of Anterior Teeth with Orthodontic Mini-Implant

343

Prosthetic Rehabilitation of Nasal Defect: A Case Report

344

Prosthetic replacement in the treatment of osteoarthritis of the shoulder: Early results of 268 cases

345

Prosthetic replacement of the aorta is a risk factor for aortic root aneurysm development

346

Prosthetic Replacement of the Ascending Aorta Increases Wall Tension in the Residual Aorta

347

Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) scleral lens for Salzmann’s nodular degeneration

348

Prosthetic replacement of the tricuspid valve: biological or mechanical?

349

Prosthetic replacement of tricuspid valve: bioprosthetic or mechanical

350

Prosthetic treatment and functional recovery of the shoulder after tumor resection 10 years ago: A case report

351

Prosthetic Tricuspid Valve Thrombosis: Three Case Reports and Literature Review

352

Prosthetic Valve Candida Endocarditis: A Case Report with 18FFDG-PET/CT as Part of the Diagnostic Workup

353

Prosthetic Valve Endocarditis

354

Prosthetic valve endocarditis caused by multidrug-resistant Candida albicans in a patient with myelodysplasia syndrome: A case report and literature review

355

Prosthetic valve endocarditis caused by Staphylococcus capitis

356

Prosthetic valve endocarditis: clinicopathological correlates in 122 surgical specimens from 116 patients (1985–2004)

357

Prosthetic Valve Endocarditis: Early Outcome following Medical or Surgical Treatment

358

Prosthetic valve in the pulmonary position, a late complication after total correction of tetralogy of fallot, a new controversial topic in cardiac surgery

359

Prosthetic valve obstruction: thrombolysis versus operation: Updated in 2000

360

Prosthetic valve replacement in ebstein’s malformation: 30-year follow-up

361

Prosthetic valve thrombosis with adequate anticoagulation

362

Prosthetic valve type for patients undergoing aortic valve replacement: a decision analysis

363

Prosthetic vascular grafts: Wrong models, wrong questions and no healing

364

Prosthetically driven immediate implant placement at lower molar area; an anatomical study

365

Prosthetic-joint-associated infections

366

Prosthetic-vein composite graft with remote popliteal arteriovenous fistula

367

Prosthodontic management of a patient with Gardner’s syndrome: A clinical case report

368

Prosthodontic Management of Implant Therapy

369

Prosthodontic management of ridge deficiencies

370

Prosthodontic Management of Xerostomic Patient: A Technical Modification

371

Prosthodontic Rehabilitation of a Bruxer Patient with Severely Worn Dentition: A Clinical Case Report

372

Prosthodontic rehabilitation of a patient with multimodality therapy for the management of oral melanoma: A case report

373

Prosthodontic Rehabilitation of Hypohidrotic Ectodermal Dysplasia in Two Young Sisters With Fixed Prostheses: Clinical Case Report

374

PROSTHODONTIC TREATMENT OF A PATIENT WITH RHEUMATOID ARTHRITIS WITH SEVERE CONDYLAR RESORPTION: 4-YEAR FOLLOW-UP

375

PROSTHODONTIC TREATMENTS, MATERIALS AND TECHNOLOGIES: THE ROLE OF THE RELATIONSHIP OF CLIN IC IANS, ACADEMIA AND INDUSTRY IN DELIVERING TH E BENEFITS OF THEIR SC IENCE TO PUBLIC.

376

Prosthodontics specialization programs around the globe

377

Prostitutes are people too

378

Prostitutes, prostitution and STD/HIV transmission in Mainland China

379

Prostitution and health

380

Prostitution and racialised sexuality: the regulation of prostitution in Britain and the British Empire before the Contagious Diseases Acts

381

Prostitution, public health, and human-rights law

382

Prostitution: to decriminalise or to legalise

383

Prostitution: to decriminalise or to legalise

384

Prostogram-predicted brachytherapy outcomes may not be universally accurate: An analysis based on The M.D. Anderson Cancer Center experience with I-125 brachytherapy

385

Prostug 01 - ةtude randomisée de phase III comparant lʹirradiation du pelvis et de la loge prostatique à lʹirradiation de la loge prostatique seule chez les patients atteints dʹun adénocarcinome prostatique classe T1b T1c T2 T3 N0 M0

386

Pro-Substance P for Evaluation of Risk in Acute Myocardial Infarction

387

Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro

388

Pro-survival and pro-growth effects of stress-induced nitric oxide in a prostate cancer photodynamic therapy model

389

ProSynth: an integrated prosodic approach to device-independent, natural-sounding speech synthesis

390

Protaglandin E2 Inhibition and Aqueou Concentration of Ketorolac 0.4% (Acular L) and Nepafenac 0.1% (Nevanac) in Patient Undergoing Phacoemulification

391

Protaglandin E2 Inhibition and Aqueou Concentration of Ketorolac 0.4% and Nepafenac 0.1% in Patient Undergoing Phacoemulification

392

Protaglandin Increae Trabecular Mehwork Outflow Facility in Cultured Human Anterior egment Original Reearch Article

393

Protagonist in chemistry

394

Protagonist in Chemistry Jonathan R. Dilworth

395

Protagonists in Chemistry

396

Protagonists in chemistry

397

Protagonists in chemistry

398

PROTAGONISTS IN CHEMISTRY

399

PROTAGONISTS IN CHEMISTRY

400

Protagonists in chemistry

401

Protagonists in Chemistry: Achim Müller

402

Protagonists in Chemistry: Prof. Jon Zubieta

403

Protamine 2 Deficiency Leads to Sperm DNA Damage and Embryo Death in Mice

404

Protamine Enhances Fibrinolysis by Decreasing Clot Strength: Role of Tissue Factor-Initiated Thrombin Generation

405

Protamine induces endothelium-dependent vasodilatation of the pulmonary artery

406

Protamine induces vasorelaxation of human internal thoracic artery by endothelial NO-synthase pathway

407

Protamine Ratio as Predictor of the Fertility Potential of Sperm by Couple Undergoing ICSI

408

Protamine sulfate protects exogenous DNA against nuclease degradation but is unable to improve the efficiency of bovine sperm mediated transgenesis

409

Protamine-induced biosilica as efficient enzyme immobilization carrier with high loading and improved stability

410

Protamine-induced DNA compaction but not aggregation shows effective radioprotection against double-strand breaks

411

Protandric hermaphroditism in the whale-fall bivalve mollusc Idas washingtonia

412

ProTaper NT system

413

Protaphorura tricampata, a euedaphic and highly permeable springtail that can sustain activity by osmoregulation during extreme drought

414

Protean Faces of Infective Endocarditis in Renal Transplant Recipients

415

Protean infectious types and frequent association with neurosurgical procedures in adult Serratia marcescens CNS infections: report of two cases and review of the literature

416

Protease (PrA and PrB) and prolyl and arginyl aminopeptidase activities from Debaryomyces hansenii as a function of growth phase and nutrient sources

417

Protease Accessibility Laddering: A Proteomic Tool for Probing Protein Structure

418

Protease activated receptors modulate aortic vascular tone

419

Protease activation in glycerol-based deep eutectic solvents

420

Protease activity and the ultrastructure of broiler chicken PSE (pale, soft, exudative) meat

421

Protease activity higher in postmortem water buffalo meat than Brahman beef

422

Protease activity impacts flesh colour during post-mortem storage of farmed Atlantic halibut (Hippoglossus hippoglossus): A condition referred to as chalky halibut

423

Protease activity in the mouse dental follicle during tooth eruption

424

Protease activity of Oenococcus oeni viable cells on red wine nitrogenous macromolecular fraction in presence of SO2 and ethanol

425

Protease and esterase activity of staphylococci

426

Protease and lipase activity of Staphylococcus aureus obtained from meat, chicken and meatball samples

427

Protease and urease production during utilization of diesel by fluorescent Pseudomonas species isolated from local soil

428

Protease autolysis in heavy-duty liquid detergent formulations: effects of thermodynamic stabilizers and protease inhibitors

429

Protease B from Debaryomyces hansenii: purification and biochemical properties

430

Protease biosensing on novel high surface area organosilicate nanoporous films

431

Protease C of Erwinia chrysanthemi: the crystal structure and role of amino acids Y228 and E189

432

Protease cell wall degradation of Chlorella vulgaris: Effect on methane production

433

PROTEASE EXCRETION DURING PINEAPPLE MICROPROPAGATION IN TEMPORARY IMMERSION BIOREACTORS

434

Protease extraction from soil by sodium pyrophosphate and chemical characterization of the extracts

435

Protease extraction from soil by sodium pyrophosphate and chemical characterization of the extracts

436

Protease increases fermentation rate and ethanol yield in dry-grind ethanol production

437

Protease inhibition prevents sarcoplasmic reticulum dysfunction in ischemic-reperfused hearts

438

Protease inhibitor (PI) mediated defense in leaves and flowers of pigeonpea (protease inhibitor mediated defense in pigeonpea)

439

Protease inhibitor activities and isoflavone content in commercial soymilks and soy-based infant formulas sold in Ottawa, Canada

440

Protease inhibitor activities and isoflavone content in commercial soymilks and soy-based infant formulas sold in Ottawa, Canada

441

Protease inhibitor from Moringa oleifera with potential for use as therapeutic drug and as seafood preservative

442

Protease inhibitor MG132 in cloning: no end to the nightmare

443

Protease inhibitor said to be in short supply

444

Protease inhibitor-associated hyperglycaemia

445

Protease Inhibitor-Associated Hyperglycemia in Mexican Patients with HIV Infection

446

Protease inhibitor-based HAART, HDL, and CHD-risk in HIV-infected patients

447

Protease inhibitors and adipocyte differentiation in cell culture

448

Protease inhibitors and cardiovascular outcomes in patients with HIV-1

449

Protease inhibitors decrease the resistance of Vitaceae to Plasmopara viticola

450

Protease inhibitors fly through FDA

451

Protease inhibitors for treatment of chronic hepatitis C—a new target for the magic bullet identified

452

Protease inhibitors from a Slovenian Lake Bled toxic waterbloom of the cyanobacterium Planktothrix rubescens

453

Protease inhibitors from a water bloom of the cyanobacterium Microcystis aeruginosa

454

Protease inhibitors from several classes work synergistically against Callosobruchus maculatus

455

Protease inhibitors from three fishpond water blooms of Microcystis spp.

456

Protease inhibitors suppress TGF-β generation by hepatic stellate cells

457

Protease inhibitors vindicated

458

Protease inhibitors. Part 8: synthesis of potent Clostridium histolyticum collagenase inhibitors incorporating sulfonylated l-alanine hydroxamate moieties Original Research Article

459

Protease inhibitors: synthesis of bacterial collagenase and matrix metalloproteinase inhibitors incorporating arylsulfonylureido and 5-dibenzo-suberenyl/suberyl moieties Original Research Article

460

Protease inhibitors: synthesis of Clostridium histolyticum collagenase inhibitors incorporating sulfonyl- -alanine hydroxamate moieties

461

Protease inhibitors: Synthesis of matrix metalloproteinase and bacterial collagenase inhibitors incorporating 5-amino-2-mercapto-1,3,4-thiadiazole zinc binding functions

462

Protease Power Strokes Force Proteins to Unfold

463

Protease produced by Pseudomonas aeruginosa K-187 and its application in the deproteinization of shrimp and crab shell wastes

464

Protease production by Burkholderia pseudomallei and virulence in mice

465

Protease supplementation of sorghum-based broiler diets enhances amino acid digestibility coefficients in four small intestinal sites and accelerates their rates of digestion

466

Protease Yoga: Extreme Flexibility of a Matrix Metalloproteinase

467

Protease-activated receptor 4-like peptides bind to thrombin through an optimized interaction with the enzyme active site surface

468

Protease-activated receptor-2 (PAR-2) regulates enterotoxigenic Escherichia coli-induced diarrhea during weaning in piglets

469

Protease-Activated Receptor-2 (PAR-2): Structure-Function Study of Receptor Activation by Diverse Peptides Related to Tethered-Ligand Epitopes

470

Protease-activated receptor-2 induces proinflammatory cytokine and chemokine gene expression in canine keratinocytes

471

Protease-activated receptor-2 induces proinflammatory cytokine and chemokine gene expression in canine keratinocytes

472

Protease-activated receptor-2 modulates hepatic stellate cell collagen release and apoptotic status

473

Protease-Activated Receptor-2 Regulates the Innate Immune Response to Viral Infection in a Coxsackievirus B3–Induced Myocarditis

474

Protease-activated receptors and endothelial prostanoid production

475

Protease-activated receptors expression in gingiva in periodontal health and disease

476

Protease-catalysed synthesis of Z-l-aminoacyl-l-caprolactam amides from Z-protected amino acid esters and dl-α-amino-ε-caprolactam

477

Protease-catalyzed dipeptide synthesis from N-protected amino acid carbamoylmethyl esters and free amino acids in frozen aqueous solutions

478

Protease-catalyzed tripeptide (RGD) synthesis

479

Protease-Containing Silicates as Active Antifouling Materials

480

Protease-Dependent T Cell Activation: Ligation of Effector Cell Protease Receptor-1 (EPR-1) Stimulates Lymphocyte Proliferation

481

Protease-induced aggregation of bovine (alpha)-lactalbumin: Identification of the primary associating fragment

482

Protease-mediated preparation of valganciclovir intermediate

483

Proteases and cellular regulation in plants

484

Proteases Detection of in vitro culture of midgut cells from Hyalomma anatolicum anatolicum (Acari: Ixodidae)

485

Proteases Detection of in vitro culture of midgut cells from Hyalomma anatolicum anatolicum (Acari: Ixodidae)

486

Proteases in fish and shellfish: Role on muscle softening and prevention

487

Proteases, growth factors, chemokines, and the microenvironment in prostate cancer bone metastasis

488

Proteases: The Tip of the Iceberg

489

Proteasomal degradation of oxidatively damaged endogenous histones in K562 human leukemic cells

490

Proteasomal degradation pathways in Trametes versicolor and Phlebia radiata

491

Proteasomal Degradation Resolves Competition between Cell Polarization and Cellular Wound Healing

492

Proteasomal Interference Prevents Zona Pellucida Penetration and Fertilization in Mammals

493

Proteasomal processing of nuclear autoantigens in systemic autoimmunity

494

Proteasomal recognition of ubiquitylated substrates

495

Proteasomal recognition of ubiquitylated substrates

496

Proteasome activation by poly-ADP-ribose-polymerase in human myelomonocytic cells after oxidative stress

497

Proteasome Activator PA28 and Its Interaction with 20 S Proteasomes

498

Proteasome activity and the post-translational control of sucrose synthase stability in maize leaves

499

Proteasome Activity in Parkinsonism through D1 Dopamine Receptor

500

Proteasome and peptidase function in MHC-class-I-mediated antigen presentation

501

Proteasome Assembly Triggers a Switch Required for Active-Site Maturation

502

Proteasome Inhibition Attenuates Infarct Size and Preserves Cardiac Function in a Murine Model of Myocardial Ischemia-Reperfusion Injury

503

Proteasome Inhibition by Carfilzomib Induced Apotosis and Autophagy in a T-cell Acute Lymphoblastic Leukemia Cell Line

504

Proteasome Inhibition by Fellutamide B Induces Nerve Growth Factor Synthesis Original Research Article

505

Proteasome inhibition by peptide-semicarbazones Original Research Article

506

Proteasome inhibition by the natural products epoxomicin and dihydroeponemycin: Insights into specificity and potency

507

Proteasome inhibition in human breast cancer cells with high catechol-O-methyltransferase activity by green tea polyphenol EGCG analogs Original Research Article

508

Proteasome Inhibition in Neuronal Cells Induces a Proinflammatory Response Manifested by Upregulation of Cyclooxygenase-2, Its Accumulation as Ubiquitin Conjugates, and Production of the Prostaglandin PGE2

509

Proteasome inhibition induces both pro- and anti-cell death pathways in prostate cancer cells

510

Proteasome Inhibition Induces Nuclear Translocation of the Dioxin Receptor Through an Sp1 and Protein Kinase C-Dependent Pathway

511

Proteasome inhibition protects osteoblasts from glucocorticoid-induced damage, and enhances glucocorticoid-induced toxicity against osteoclasts

512

Proteasome Inhibition Sensitizes Non–Small-Cell Lung Cancer to Gemcitabine-Induced Apoptosis

513

Proteasome inhibition: a new pathway in cancer therapy

514

Proteasome inhibition: A new therapeutic strategy to cancer treatment

515

Proteasome inhibition: a novel approach to cancer therapy

516

Proteasome inhibitor PSI induces apoptosis in human mesothelioma cells

517

Proteasome Inhibitors in Cancer Therapy.J. Adams, Editor, Humana Press, Totowa (2004).

518

Proteasome Inhibitors in Myocardial Ischemia, Some Concerns

519

Proteasome inhibitors induce apoptosis of prostate cancer cells by inducing nuclear translocation of IκBα

520

Proteasome inhibitors reproduce preconditioning and postconditioning in cardiomyocyte culture

521

Proteasome Inhibitors: An Expanding Army Attacking a Unique Target Review Article

522

Proteasome inhibitors: from research tools to drug candidates Review Article

523

Proteasome inhibitors: synthesis and activity of arecoline oxide tripeptide derivatives

524

Proteasome mediates removal of proteins oxidized during myocardial ischemia

525

Proteasome modulates mitochondrial function during cellular senescence

526

Proteasome Regulation by ADP-Ribosylation

527

Proteasome synthesis and assembly are required for survival during stationary phase

528

Proteasome-Dependent Turnover of Protein Disulfide Isomerase in Oxidatively Stressed Cells

529

Proteasome-inhibitory and cytotoxic constituents of Garcinia lateriflora: absolute configuration of caged xanthones

530

Proteasome-Mediated Degradation of p21 via N-Terminal Ubiquitinylation

531

Proteasome-mediated degradation of tau proteins occurs independently of the chymotrypsin-like activity by a nonprocessive pathway

532

Proteasome-Mediated Processing of Def1, a Critical Step in the Cellular Response to Transcription Stress

533

Proteasome-Mediated Turnover of the Transcription Coactivator NPR1 Plays Dual Roles in Regulating Plant Immunity

534

Proteasomes and proteasome inhibition in the central nervous system

535

Proteasomes Can Degrade a Significant Proportion of Cellular Proteins Independent of Ubiquitination

536

Proteasomes in Protein Homeostasis of Pluripotent Stem Cells

537

Proteasomes: Machines for All Reasons

538

Protect and Appreciate–Notes on the Justification of User-Centered Design

539

Protect and survive

540

Protect children from tobacco addiction, says WHO

541

Protect Your Kidneys, Save Your Heart The Message for World Kidney Day 2011

542

ProTECT: A Randomized Clinical Trial of Progesterone for Acute Traumatic Brain Injury

543

Protected aminooxyprolines for expedited library synthesis: Application to Tsg101-directed proline–oxime containing peptides

544

Protected anodes for lithium-air batteries

545

Protected area acquisition costs show economies of scale with area

546

Protected area downgrading, downsizing, and degazettement (PADDD) in Africa, Asia, and Latin America and the Caribbean, 1900–2010

547

Protected Area Management: Principles and Practices: By Graeme Worboys, Michael Lockwood and Terry De Lacy. Oxford University Press (253 Normanby Street, South Melbourne, Australia) 2001 xix+399 pp (tables, figures, appendix, bibliography, index) AU$75.00

548

Protected area managers perceptions of community conservation training in West and Central Africa

549

Protected Area Theory at the System Level

550

Protected area zoning for conservation and use: A combination of spatial multicriteria and multiobjective evaluation

551

Protected areas and coastal and ocean management in México

552

Protected areas and landscape conservation in the Lombardy plain (northern Italy): an appraisal

553

Protected Areas and Regional Sustainability: Surveying Decision Makers in the Lake Superior Basin

554

Protected areas as attractions

555

Protected areas do not fulfil the wintering habitat needs of the trans-Saharan migratory Montagu’s harrier

556

Protected areas for environmental sustainability in Nigeria

557

Protected areas for seabirds in German offshore waters: Designation, retrospective consideration and current perspectives

558

Protected areas in a landscape dominated by logging – A connectivity analysis that integrates varying protection levels with competition–colonization tradeoffs

559

Protected areas in climate space: What will the future bring?

560

Protected areas in marine resource management: another look at the economics and research issues

561

Protected areas in the Atlantic facing the hazards of micro-plastic pollution: First diagnosis of three islands in the Canary Current

562

Protected areas shape the spatial distribution of a European lynx population more than 20 years after reintroduction

563

Protected areas, local governments, and strategic interactions: The case of the ICMS-Ecolَgico in the Brazilian state of Paranل

564

Protected areas, wildlife conservation, and local welfare

565

Protected areas: a prism for a changing world

566

Protected Carotid Stenting in High-Risk Patients With Severe Carotid Artery Stenosis Original Research Article

567

Protected Designation of Origin as a Certified Quality System in the Andalusian olive oil industry: Adoption factors and management practices

568

Protected for ever? : Factors shaping the future of protected areas policy

569

Protected forests in Europe approaches-harmonising the definitions for international comparison and forest policy making

570

Protected operators in N=2,4 supersymmetric theories Original Research Article

571

Protected points in k-ary trees

572

Protected points in ordered trees Original Research Article

573

Protected propargylic acetals. Nicholas–Prins cyclization leading to functionalized 2-alkynyl-tetrahydropyrans. Intramolecular trapping by allenes

574

Protected Shared Variables in VHDL: IEEE Standard 1076a

575

Protected species outside the protected areas: Peopleʹs attitude, threats and conservation of the Yellow Monitor (Varanus flavescens) in the Far-western Lowlands of Nepal

576

Protected surface-enhanced resonance Raman spectroscopy for the study of geochemically significant chlorophyll transformation products

577

Protected Values and Omission Bias

578

Protected Values,

579

Protected wading bird species threaten relict centenarian cork oaks in a Mediterranean Biosphere Reserve: A conservation management conflict

580

protecThe effects of menstrual cycle on cardiac conduction system

581

Protecting a whole building from critical indoor contamination with optimal sensor network design and source identification methods

582

Protecting abused children

583

Protecting Against Cocaine, Heroin, and Sarin Gas Review Article

584

PROTECTING AGAINST NOISE TRAUMA BY SOUND CONDITIONING

585

Protecting against Streptococcus zooepidemicus opportunism: The challenge of vaccine design

586

Protecting american health care consumers: Eleanor DeArman Kinney; Duke University Press, Durham, London, 2002, 277pp., 42.95 (cloth)

587

Protecting an organization’s digital public relations assets

588

Protecting and managing private farmland and public greenways in the urban fringe

589

Protecting and preserving traditional knowledge and plant genetic resources: is ASEAN there yet?

590

Protecting and sharing biodiversity and traditional knowledge: Holder and user tools

591

Protecting Animals Rights in Armed Conflicts from the Perspective of Islam and International Humanitarian Law

592

Protecting assets—more than insurance

593

Protecting BGP routes to top-level DNS servers

594

Protecting Biodiversity outside Natural Forests: Environmentalfriendly Oil Palm Plantations as an Off-reserve Strategy in Peninsular Malaysia

595

Protecting BOPP film from UV degradation with an atomic layer deposited titanium oxide surface coating

596

Protecting Building Environments from Airborne Chemical, Biological, or Radiological Attacks

597

Protecting Buildings against Vehicle Bomb Attacks

598

Protecting bursty applications against traffic aggressiveness

599

Protecting child health by preventing school-related foodborne illnesses: Microbiological risk assessment of hygiene practices, drinking water and ready-to-eat foods in Italian kindergartens and schools

600

Protecting children and prioritising evidence

601

Protecting children from maltreatment in a hospital setting

602

Protecting children from the dangers of urban poverty

603

Protecting children in the new media environment: Rising to the regulatory challenge?

604

Protecting civil society from terrorism: the search for a sustainable strategy

605

Protecting Civilians…or Soldiers? Humanitarian Law and the Economy of Risk in Iraq

606

Protecting colour per se in the United States

607

Protecting Consumers in a Transition to Competition

608

Protecting consumers through protection: The role of tariff-induced technology transfer

609

Protecting copper from electrochemical degradation by graphene coating Original Research Article

610

Protecting Critical Data

611

Protecting crops from non-persistently aphid-transmitted viruses: A review on the use of barrier plants as a management tool

612

Protecting cryptographic keys: the trace-and-revoke approach

613

Protecting cucumber from Meloidogyne incognita using graft onto resistant cucurbit rootstocks and antagonistic marigold as an alternative to nematicide

614

Protecting Earth-orbiting spacecraft against micro-meteoroid/orbital debris impact damage using composite structural systems and materials: An overview Review Article

615

Protecting e-commerce agents from defamation

616

Protecting Eden: markets or government?

617

Protecting effect of vitamin E supplementation on submaximal exercise-induced oxidative stress in sedentary dogs as assessed by erythrocyte membrane fluidity and paraoxonase-1 activity

618

Protecting elders: Regulating intergenerationally transmitted debt in Australia

619

Protecting endangered species: When are shoot-on-sight policies the only viable option to stop poaching?

620

Protecting environmental quality and human health: strategies for harmonisation

621

Protecting everybodyʹs genetic data

622

Protecting exposed tissues with external ultrasonic super-hydration

623

Protecting File Systems with Transient Authentication

624

Protecting fluency development of dysfluent preschoolers

625

Protecting foreign inventors or a learning channel? Evidence from patents granted in Taiwan

626

Protecting group directed cyclization: asymmetric synthesis of both cis- and trans-dihydrexidine from a common precursor

627

Protecting group directed ring-closing metathesis (RCM): the first total synthesis of an anti-malarial nonenolide

628

Protecting group directed stereoselective reduction of an epi-inosose: efficient synthesis of epi-inositol

629

Protecting group effect on the 1,2-dehydrogenation of 19-hydroxysteroids: a highly efficient protocol for the synthesis of estrogens

630

Protecting group free syntheses of (±)-columbianetin and (±)-angelmarin

631

Protecting group migration in the chemistry of 1-t-butyldimethylsilyl-4-hydroxymethyl-2-azetidinone

632

Protecting groups for stabilization of inter-element linkages

633

Protecting Groups, Edited by P.J. Kocienski, Georg Thieme Verlag, Stuttgart, 2000, pp. xv+260, ISBN 3-13-137002-5; DM 99, SFr 90, Euro 50.62

634

Protecting health care workers from SARS and other respiratory pathogens: A review of the infection control literature Review Article

635

Protecting health care workers from SARS and other respiratory pathogens: Organizational and individual factors that affect adherence to infection control guidelines

636

Protecting Healthcare Workers From COVID-19 and the Assaulting Society: Indian Perspective

637

Protecting host-based intrusion detectors through virtual machines

638

Protecting Intellectual Freedom in Your Academic Library, by Barbara M. Jones. Chicago: American Library Association, 2009. 256p. $55.00. ISBN 978-0-8389-3580-4.

639

Protecting intellectual property : Richard R. Halstead, ICSA Publishing Ltd, 2nd Edn, 1996, pp. 191, £24.95. ISBN 1-872860-93-1

640

Protecting intellectual property in digital multimedia networks

641

Protecting intellectual property rights in SELEX and aptamers

642

Protecting intellectual property rights on the information superhighways : By Joseph L. Ebersole. Washington, D.C.: Information Industry Association, March 1994. 99 pages. $95.00 (paper). Prepayme nts can be made to the IIA, 555 New Jersey Ave., NW, Suit

643

Protecting islands from invaders

644

Protecting islands from pest invasion: optimal allocation of biosecurity resources between quarantine and surveillance

645

Protecting islands from pest invasion: Response to Greenslade et al.

646

Protecting library staff, users, collections and facilities: by Pamela J. Cravey; how-to-do-it manuals for librarians, 103. New York: Neal-Schuman publishers, 2001, 175 pp, $55.00, soft, ISBN 1555703925

647

Protecting marine ecosystems: A necessity for environmental conservation

648

Protecting mental health clientsʹ dignity — The importance of legal control

649

Protecting mobile code in the world

650

Protecting Mobile TV Multimedia Content in DVB/GPRS Heterogeneous Wireless Networks

651

Protecting more than the wetland: The importance of biased sex ratios and habitat segregation for conservation of the Hine’s emerald dragonfly, Somatochlora hineana Williamson Original Research Article

652

Protecting multicast sessions in WDM optical mesh networks

653

Protecting Native Customary Rights: Is Legal Recourse Viable Alternative?

654

PROTECTING NON-MUSLIM: ITS IMPLEMENTATION DURING EARLY MUSLIM RULE OF ISLAMICJERUSALEM

655

Protecting Pakistan’s health during the global economic crisis

656

Protecting patient care and public safety in the managed-care era

657

Protecting patients and staff in residential treatment centers during exposure to COVID-19: commentary

658

Protecting patients and surgeons: implications of the Data Protection Act 1998 in plastic surgical practice

659

Protecting Patients from Harm: Legislating Vaccinations for Healthcare Workers

660

Protecting patientsʹ privacy

661

Protecting patientsʹ privacy

662

Protecting plants from elephants: botanical reserve scenarios within the Addo Elephant National Park, South Africa Original Research Article

663

Protecting Postextubation Respiratory Failure and Reintubation by High-Flow Nasal Cannula Compared to Low-Flow Oxygen System: Single Center Retrospective Study and Literature Review

664

Protecting privacy and anonymity in pervasive computing: trends and perspectives

665

Protecting privacy in computerized me dical information : By U.S. Congress, Office of Technology Assessme nt. Washington, D.C.: GPO, 1993. 157pp. $10.00 (softcover), OTA-TCT-576. ISBN 0-16-042074-1. SuDoc Y3.T22/2:P 2/12

666

Protecting privacy in public? Surveillance technologies and the value of public places

667

Protecting professors from the burden of teaching

668

Protecting profits

669

Protecting renal function in the hypertensive patient: Clinical guidelines

670

Protecting research and technology from espionage

671

Protecting research subjects under the waiver of informed consent for emergency research: Experiences with efforts to inform the community

672

Protecting Research Subjects, Employees and Researchers: Implications for Software Engineering

673

Protecting River Environment through Proper Management of Material Mining by Matrix Method (Case Study of A la River in Iran)

674

Protecting seashores

675

Protecting Sites of Special Scientific Interest: Intrinsic and Utilitarian Values

676

Protecting stainless steel by glass coating during slab reheating

677

Protecting stallion sperm during cooling and freezing with caseinate based extenders

678

Protecting Students’ Psychological Well-being During COVID-19 Pandemic: The Role of Optimism and Gratitude

679

Protecting Surfaces Using One-Dimensional Nanostructures

680

Protecting the African elephant: A dynamic bioeconomic model of ivory trade Original Research Article

681

Protecting the Ame rican Home land: One Year On: Michael E. O’Hanlon, Peter R. Orszag, et al. Washington, D.C.: Brookings Institution Press, 2003. xl, 188 pp. $17.95 (paper). ISBN 0-8157-6453-7

682

Protecting the baryon asymmetry in theories with R-parity violation

683

Protecting the brain:how do we measure success?

684

Protecting the childʹs abdomen: a retractable bicycle handlebar

685

Protecting the Commons. A Framework for Resource Management in the Americas

686

Protecting the commons. A framework for resource management in the Americas: Edited by Joanna Burger, Elinor Ostrom, Richard B. Norgaard, David Policansky and Bernard D. Goldstein, Island Press, Washington DC, 2001, xii+342 pp., index (paperback). ISBN 1-

687

Protecting the core competencies of a company: Intangible asset security

688

Protecting the Critical National Infrastructure — Developing a Method for the Measurement of Threat Agents in an Information Environment

689

Protecting the Crossover Right Internal Thoracic Artery Bypass Graft With a Pedicled Thymus Flap

690

Protecting the earthʹs ozone layer

691

Protecting the Egyptian monuments Fundamentals of proficiency

692

Protecting the elderly from infection

693

Protecting the forest from the trees: the social costs of energy production in Sweden

694

Protecting the global information commons

695

Protecting the hand that feeds us: Seagrass (Zostera marina) serves as commercial juvenile fish habitat

696

Protecting the head/disk interface from the chemical environment with disk drive filtration

697

Protecting the Heart of the American Athlete: Proceedings of the American College of Cardiology Sports and Exercise Cardiology Think Tank October 18, 2012, Washington, DC

698

Protecting the Internet from distributed denial-of-service attacks: a proposal

699

Protecting the legacy: The nurse-patient relationship and the therapeutic alliance

700

Protecting the marine environment from land-based activities: a global programme of action

701

Protecting the Market from “Hockey Stick” Pricing: How the Public Utility Commission of Texas is Dealing with Potential Price Gouging

702

Protecting the mental health of Gazaʹs inhabitants

703

Protecting the North-East Atlantic: enhancing synergies by institutional interplay

704

Protecting the Ozone Layer: The United Nations History: By Stephan O. Andersen, K. Madhava Sarma, Earthscan Publications, London, 2002. 513 pp.; ISBN: 1-85383-905-1

705

Protecting the privacy of third-party information: Recommendations for social and behavioral health researchers

706

Protecting the public health — the role of environmental health

707

Protecting the right to health of internally displaced mothers and children: the imperative of inter-cluster coordination for translating best practices into effective participatory action

708

Protecting the rights of the mentally disordered in police stations: The use of the appropriate adult in England and Wales

709

Protecting the rights of those in conflict

710

Protecting the self through consumption: Status goods as affirmational commodities

711

Protecting the self: A descriptive qualitative exploration of how registered nurses cope with working in surgical areas

712

Protecting the underwater cultural heritage. The international law association draft convention

713

Protecting the vulnerable: testing times for clinical research ethics

714

Protecting trade secrets through family businesses: A case study on Nepal

715

Protecting vital sea lines of communication: A study of the proposed designation of the Straits of Malacca and Singapore as a particularly sensitive sea area

716

Protecting Water Resources from Pollution in the Lake Batllava

717

Protecting Women’s Interest (Maslahah) in Marriage Through Appointment of a Guardian (Wali) Under Islamic Law

718

Protecting wood from mould, decay, and termites with multi-component biocide systems

719

Protecting workers and the environment: An environmental NGO’s perspective on nanotechnology

720

Protecting your utilityʹs most valuable assets: Key industrial and commercial relationships—An outsiderʹs view

721

Protecting youth online: Family use of filtering and blocking software

722

Protecting-group-free catalytic asymmetric total synthesis of (−)-rosmarinecine

723

Protection against Alzheimerʹs disease?

724

Protection against Apoptosis in Chicken Bursa Cells by Phorbol Ester in Vitro

725

Protection against arrhythmias by exercise; role of nitric oxide

726

Protection against arsenic trioxide-induced autophagic cell death in U118 human glioma cells by use of lipoic acid

727

Protection against Atlantic halibut nodavirus in turbot is induced by recombinant capsid protein vaccination but not following DNA vaccination

728

Protection Against Blood-Brain Barrier Permeability as a Possible Mechanism for Protective Effects of Thymoquinone Against Sickness Behaviors Induced by Lipopolysaccharide in Rats

729

Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines

730

Protection against bovine tuberculosis induced by oral vaccination of cattle with Mycobacterium bovis BCG is not enhanced by co-administration of mycobacterial protein vaccines

731

Protection against corrosion of aluminium-SiC composites by sol–gel silica coatings

732

Protection against corrosion of magnesium alloys with both conversion layer and sol–gel coating

733

Protection against Cyclosporine-Induced Reprotoxicity by Satureja khuzestanica Essential Oil in Male Rats

734

Protection against Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Neferine, A Natural Product from Nelumbo nucifera Gaertn

735

Protection against Diabetes by MHC Heterozygosity and Reversal by Cyclophosphamide

736

Protection Against Doxorubicin-induced Nephropathy by Plantago major in Rat

737

Protection against experimental Aeromonas salmonicida infection in carp by oral immunisation with bacterial antigen entrapped liposomes

738

Protection against free radicals (UVB irradiation) of a water-soluble enzymatic extract from rice bran. Study using human keratinocyte monolayer and reconstructed human epidermis

739

Protection against gastrointestinal diseases—Present facts and future developments

740

Protection against high-energy line breaks in WWER power plants

741

Protection against high-energy line breaks in WWER power plants Original Research Article

742

Protection against hydrogen peroxide induced oxidative damage in rat erythrocytes by Mangifera indica L. peel extract

743

Protection against Hypoxia-reoxygenation in the Absence of Poly (ADP-ribose) Synthetase in Isolated Working Hearts

744

Protection against iron- and hydrogen peroxide-dependent cell injuries by a novel synthetic iron catalase mimic and its precursor, the iron-free ligand

745

Protection against ischemia-reperfusion injury in prolonged resuscitation: A case report and review of literature

746

Protection against Lawsonia intracellularis re-infection did not correlate with humoral or cell-mediated immune response

747

Protection against Lawsonia intracellularis re-infection did not correlate with humoral or cell-mediated immune response

748

Protection against Lawsonia intracellularis re-infection did not correlate with humoral or cell-mediated immune response

749

Protection against Lawsonia intracellularis re-infection did not correlate with humoral or cell-mediated immune response

750

Protection against Lawsonia intracellularis re-infection did not correlate with humoral or cell-mediated immune response

751

Protection against Lawsonia intracellularis re-infection did not correlate with humoral or cell-mediated immune response

752

Protection against lead contamination by strains of lactic acid bacteria from fermented camel milk

753

Protection against Lethal Toxoplasmosis in Mice by an Avirulent Strain of Toxoplasma gondii: Stimulation of IFN-gamma and TNF-alpha Response

754

Protection against lipopolysacharide-induced myocardial dysfunction in mice by cardiac-specific expression of soluble Fas

755

Protection against Morphine-Induced Inhibitory Avoidance Memory Impairment in Rat by Curcumin: Possible Role of Nitric Oxide/ cAMP-Response Element Binding Protein Pathway

756

Protection against Murine Coxsackievirus B3 Myocarditis by T Cell Vaccination

757

Protection Against Myocardial Ischemic/Reperfusion Injury by Inhibitors of Two Separate Pathways of Na+Entry

758

Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: The role of iron chelation

759

Protection Against Oxidative Damage and Cell Death by the Natural Antioxidant Ergothioneine

760

Protection against oxidative stress in Escherichia coli stationary phase by a phosphate concentration-dependent genes expression

761

Protection against oxidative stress through SUA7/TFIIB regulation in Saccharomyces cerevisiae

762

Protection against peroxynitrite reactions by flavonoids

763

Protection against persistence of hepatitis C

764

Protection against prenatal irradiation-induced genomic instability and its consequences in adult mice by Ocimum flavonoids, orientin and vicenin

765

Protection Against Radiation-Induced Duox1 and Duox2 Upregulation in Rat s Lung Tissues by a Combination of Curcumin and L-Selenomethionine

766

Protection against renal ischaemia/reperfusion injury: A comparative experimental study of the effect of ischaemic preconditioning vs. postconditioning

767

Protection against tetanus in the aged people in the Czech Republic—cross-sectional study

768

Protection against the Omicron and Subsequent Coronavirus Variants: Medical-grade Masking, Third Dose Vaccination, Updating Vaccines, and Pursuing Universal Vaccine

769

Protection against UVB irradiation by natural filters extracted from lichens

770

Protection against UV-light-induced skin carcinogenesis in SKH-1 high-risk mice by sulforaphane-containing broccoli sprout extracts

771

Protection and antibody isotype responses against Fasciola hepatica with specific antibody to pIII-displayed peptide mimotopes of cathepsin L1 in sheep

772

Protection and antibody response induced by intramuscular DNA vaccine encoding for viral haemorrhagic septicaemia virus (VHSV) G glycoprotein in turbot (Scophthalmus maximus)

773

Protection and Commissioning of Multifunction Digital Transformer Relays at Medium Voltage Industrial Facilities

774

Protection and Immune Responses Elicited by rSAG1-PLGA Nanoparticles in C57BL/6 Against Toxoplasma gondii

775

Protection and jobs: explaining the structure of trade barriers across industries

776

Protection and optimization of equipment from So2 and So3

777

Protection and Recycling of α-Tocopherol in Human Erythrocytes by Intracellular Ascorbic Acid

778

Protection and reversal of hepatic fibrosis by red wine polyphenols in hyperhomocysteinemic mice

779

Protection and social order

780

Protection and the gainful effects of foreign capital

781

Protection and unemployment

782

Protection Approaches for Dynamic Traffic in IP/MPLS-over-WDM Networks

783

Protection areas of the Sمo Pedro do Sul Spa, Portugal

784

Protection Behaviors and Related Factors Against COVID‑19 in the Healthcare Workers of the Hospitals in Iran: A Cross‑Sectional Study

785

Protection behaviour: a phenomenon affecting organ and tissue donation in the 21st century?

786

Protection by [6]-shogaol against lipopolysaccharide-induced toxicity in murine astrocytes is related to production of brain-derived neurotrophic factor

787

Protection by beta-Hydroxybutyric acid against insulin glycation, lipid peroxidation and microglial cell apoptosis

788

Protection by coffee against somatic genotoxicity in drosophila: Role of bioactivation capacity

789

Protection by Cyclosporin A of Ischemia/Reperfusion-Induced Damage in Isolated Rat Hearts

790

Protection by desferrioxamine and other hydroxamic acids against tetrachlorohydroquinone-induced cyto- and genotoxicity in human fibroblasts

791

Protection by EGb 761 against β-amyloid-induced neurotoxicity: Involvement of NF-κB, SIRT1, and MAPKs pathways and inhibition of amyloid fibril formation

792

Protection by fungal starters against growth and secondary metabolite production of fungal spoilers of cheese

793

Protection by glycine against hypoxic injury of rat hepatocytes: inhibition of ion fluxes through nonspecific leaks

794

Protection by Inhibition of Poly (ADP-ribose) Synthetase Against Oxidant Injury in Cardiac MyoblastsIn Vitro

795

Protection by L-fucose and fucose-rich polysaccharides against ROS-produced cell death in presence of ascorbate

796

Protection by low-dose γ radiation on doxorubicin-induced nephropathy in rats pretreated with curcumin, green tea, garlic or L-carnitine

797

Protection by lysosomal hydrolase inhibitors against cytotoxicity of 2-chloroethylethyl sulfide

798

Protection by MnTE-2-PyP5+, a cell permeable SOD mimetic, against cytokine-induced myocardial dysfunction in isolated working mouse hearts

799

Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus

800

Protection by recombinant viral proteins against a respiratory challenge with virulent avian metapneumovirus

801

Protection by rhamnose-rich polysaccharides against the cytotoxicity of Maillard reaction products

802

Protection by thiols of the mitochondrial complexes from 4-hydroxy-2-nonenal

803

Protection by Vitamin C of Loss of Vitamin E in Cultured Rat Hepatocytes

804

Protection capability of dual flying plates against obliquely impacting long-rod penetrators

805

Protection circuit for the T2 readout electronics of the TOTEM experiment

806

Protection circuit for the T2 readout electronics of the TOTEM experiment

807

Protection coatings for planar solid oxide fuel cell interconnect prepared by plasma spraying

808

Protection conferred by Bcl-2 expression involves reduced oxidative stress and increased glutathione production during hypothermia-induced apoptosis in AK-5 tumor cells

809

Protection co-ordination: determination of the break point set

810

Protection current distribution in reinforced concrete cathodic protection systems

811

Protection effectiveness of an oblique plate against a long rod

812

Protection Efficacy of Multivalent Egg Yolk Immunoglobulin against Eimeria tenella Infection in Chickens.

813

Protection efficiency of red radish seeds and roots against paracetamol mediated hepatotoxicity in rats

814

Protection et sûreté radiologiques en médecine Publication CIPR 73, Nucléon 97-XII

815

Protection for sale or surge protection?

816

Protection for sale under monopolistic competition

817

Protection for the good: subcategorization reduces hedonic contrast

818

Protection for Tree-Based EPON-FTTH Architecture Using Combination ACS and OXADM

819

Protection from adverse myocardial remodeling secondary to chronic volume overload in mast cell deficient rats

820

Protection from digoxin-induced coronary vasoconstriction in patients with coronary artery disease by calcium antagonists

821

Protection from endotoxic shock by EVK-203, a novel alkylpolyamine sequestrant of lipopolysaccharide Original Research Article

822

Protection from extinction in human fear conditioning

823

Protection from Feed-Forward Amplification in an Amplified RNAi Mechanism

824

Protection from garlic and linseed oil

825

Protection from harvesting restores the natural social structure of eastern wolf packs

826

Protection from HIV/AIDS: the importance of innate immunity

827

Protection from Lyme Neuroborreliosis in Nonhuman Primates with a Multiantigenic Vaccine

828

Protection from Myocardial Reperfusion Injury by Acute Administration of 17β-Estradiol

829

Protection from natural infections with enterotoxigenic Escherichia coli: longitudinal study

830

Protection from nonsteroidal anti-inflammatory drug (NSAID)-induced gastric ulcers by dietary nitrate

831

Protection from oxidative damage using Bidens pilosa extracts in normal human erythrocytes

832

Protection From Procedural Myocardial Injury by Atorvastatin Is Associated With Lower Levels of Adhesion Molecules After Percutaneous Coronary Intervention: Results From the ARMYDA-CAMs (Atorvastatin for Reduction of MYocardial Damage during Angioplasty-C

833

Protection from Radiation-Induced Male Germ Cell Loss by Sphingosine-1-Phosphate

834

Protection from the effects of metabolic inhibition and reperfusion in contracting isolated ventricular myocytes via protein kinase C activation

835

Protection in a single-address-space environment

836

Protection in an ant–plant mutualism: an adaptation or a sensory trap?

837

PROTECTION IN OPTICAL MESH NETWORKS - A COST EFFECTIVE STRATEGY BASED ON TOPOLOGICAL CONSTRAINTS

838

Protection in the absence of exclusion between two Brazilian isolates of Anaplasma marginale in experimentally infected calves

839

Protection interoperability for WDM optical networks

840

Protection issues during system restoration

841

Protection Issues‎ in SCADA Systems

842

Protection layers for the extension of slow sand filter running times in wastewater reuse

843

Protection measures for selected ITER magnet system off-normal conditions

844

Protection mechanisms of sugars during different stages of preparation process of dried lactic acid starter cultures Review Article

845

PROTECTION METHODS FROM INSECTS IN ARCHIVES AND LIBRARIES

846

Protection of 2-(3-thienyl)ethanol with 3-thienylacetic acid and hard cross-linked conducting films by electropolymerization of the ester

847

Protection of 2024-T3 aluminium alloy by corrosion resistant phytic acid conversion coating

848

Protection of 3,4-dihydroxyphenylalanine (DOPA) for Fmoc solid-phase peptide synthesis

849

Protection of a mobile agent with a reference clone

850

Protection of a Surgeon From Dangerous Needlesticks

851

Protection of alloxan monohydrate-induced testicular toxicity by Gundelia tournefortii aerial parts aqueous extract in male mice

852

Protection of AlN powder against hydrolysis using aluminum dihydrogen phosphate

853

Protection of aluminium foil AA8021 by molybdate-based conversion coatings

854

Protection of aluminum hydroxide during lyophilisation as an adjuvant for freeze-dried vaccines

855

Protection of ash (Fraxinus excelsior) trees from ozone injury by ethylenediurea (EDU): Roles of biochemical changes and decreased stomatal conductance in enhancement of growth

856

Protection of Atlantic salmon (Salmo salarL.) against an experimental infection ofAeromonas salmonicidassp.achromogenes

857

Protection of BALB/c mice against pathogenic Brucella abortus and Brucella melitensis by vaccination with recombinant Omp16

858

protection of bamboo against mould USING environment-friendly chemicals

859

Protection of blue shrimp (Litopenaeus stylirostris) against the White Spot Syndrome Virus (WSSV) when injected with shrimp lysozyme

860

Protection of calpain-I induced cTnl degradation by PKA phosphorylation in vitro

861

Protection of Calves Against Cryptosporidiosis by Hyperimmunization of Pregnant Cattle Colostrum using Oocyst Whole Antigens

862

Protection of cardiomyocyte function by propofol during simulated ischemia is associated with a direct action to reduce pro-oxidant activity

863

Protection of cavernous tissue in male spontaneously hypertensive rats: Beyond blood pressure control

864

PROTECTION OF CELLS FROM COMPLEMENT-MEDIATED ATTACK: CD59 RECEPTOR CLUSTERING FOR THE ENTRY OF MACROMOLECULES INTO HEMATOFOIETIC CELLS

865

PROTECTION OF CERTAIN AGRICULTURAL COMMODITIES FROM INSECT INFESTATION USING OZONE

866

Protection of cesium-antimony photocathodes

867

Protection of cesium-antimony photocathodes

868

Protection of chemolithoautotrophic bacteria exposed to simulated Mars environmental conditions

869

Protection of chicken against very virulent IBDV provided by in ovo priming with DNA vaccine and boosting with killed vaccine and the adjuvant effects of plasmid-encoded chicken interleukin-2 and interferon-γ

870

Protection of chickens against heterogeneous IBV strains with recombinant fowlpox virus expressing IBV S1 gene and ChIFNγ gene

871

Protection of chickens against heterogeneous IBV strains with recombinant fowlpox virus expressing IBV S1 gene and ChIFNγ gene

872

Protection of chickens against heterogeneous IBV strains with recombinant fowlpox virus expressing IBV S1 gene and ChIFNγ gene

873

Protection of chickens against heterogeneous IBV strains with recombinant fowlpox virus expressing IBV S1 gene and ChIFNγ gene

874

Protection of chickens against heterogeneous IBV strains with recombinant fowlpox virus expressing IBV S1 gene and ChIFNγ gene

875

Protection of chickens against heterogeneous IBV strains with recombinant fowlpox virus expressing IBV S1 gene and ChIFNγ gene

876

Protection of Children from Hazards of Smoking: Community Health Nurse and Primary Responsibilities

877

Protection of cobalt-based refractory alloys by chromium deposition on surface: Part I: Sub-surface enrichment in chromium by pack-cementation and diffusion

878

Protection of cobalt-based refractory alloys by chromium deposition on surface: Part II: Behaviour of the coated alloys in oxidation at high temperature

879

Protection of conjugated linoleic acids from ruminal hydrogenation and their incorporation into milk fat

880

Protection of cucumber against Pythium root rot by fluorescent pseudomonads: predominant role of induced resistance over siderophores and antibiosis

881

Protection of curcumin against fructose-induced hyperuricaemia and renal endothelial dysfunction involves NO-mediated JAK–STAT signalling in rats

882

Protection of cyanidin-3-glucoside against oxidative stress induced by acrylamide in human MDA-MB-231 cells

883

Protection of cylinders by ion-beam sputter deposition: corrosion of carbon-coated aluminium tubes

884

Protection Of Database Under Actionable Torts

885

Protection of Designs in the UK and Europe PATMG, London, May 2002

886

Protection of Distal Embolization in High-Risk Patients With Acute ST-Segment Elevation Myocardial Infarction (PREMIAR)

887

Protection of DNA and erythrocytes from free radical induced oxidative damage by black gram (Vigna mungo L.) husk extract

888

Protection of endothelial cell viability with ischemic preconditioning

889

Protection of Environment and women’s social position in Iran1 (A Community Level Study)

890

Protection of epidermal cells against UVB injury by the antioxidant selenium-containing single-chain Fv catalytic antibody

891

Protection of evolving myocardial infarction and failed PTCA

892

Protection of fish feed, made directly from marine raw materials, with natural antioxidants

893

Protection of flavonoids against hypochlorite-induced protein modifications

894

Protection of flexible pipes from dynamic surface stresses by geocell-reinforced sand backfill

895

Protection of free-living nitrogen-fixing bacteria within the soil matrix

896

Protection of Geological Heritage by a New Phenomenon in Earth Sciences: Geoconservation

897

Protection of Global Biodiversity: Converging Strategies, Edited by Lakshman D. Guruswamy and Jeffrey A. McNeely. Duke University Press, Durham, 1998, viii+425 pp. ISBN 8-223-21882

898

Protection of gnotobiotic pigs against Salmonella enterica serotype Typhimurium by rough mutant of the same serotype is accompanied by the change of local and systemic cytokine response

899

Protection of gnotobiotic pigs against Salmonella enterica serotype Typhimurium by rough mutant of the same serotype is accompanied by the change of local and systemic cytokine response

900

Protection of HealthWorkers From Tuberculosis

901

Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients

902

Protection of Hippocampal CA1 Neurons Against Ischemia/Reperfusion Injury by Exercise Preconditioning via Modulation of Bax/ Bcl-2 Ratio and Prevention of Caspase-3 Activation

903

Protection of human breast cancer cells from complement-mediated lysis by expression of heterologous CD59

904

Protection of human erythrocyte using Crinum asiaticum extract and lycorine from oxidative damage induced by 2-amidinopropane

905

Protection of Indigenous Knowledge: Mismatch Between The Convention on Biological Diversity and TRIPS Agreement

906

Protection of insulin secreting cells from nitric oxide induced cellular damage by crosslinked hemoglobin

907

PROTECTION OF INTELLECTUAL PROPERTY RIGHTS AN INDIAN PERSPECTIVE

908

Protection of iron against corrosion by coverage with Au nanoparticles and n-hexylthiol mixed films

909

Protection of iron corrosion by stearic acid and stearic imidazoline self-assembled monolayers

910

Protection of Ischemic and Reperfused Rat Heart by Aqueous Extract of Urtica Dioica

911

Protection of ischemic myocardium in dogs using intracoronary 2,3-butanedione monoxime (BDM)

912

Protection of Ischemic Preconditioning is Dependent upon a Critical Timing Sequence of Protein Kinase C Activation

913

Protection of isolated rat heart against the Ca2+ paradox. Are gap junction channels involved?

914

Protection of L. rhamnosus by spray-drying using two prebiotics colloids to enhance the viability

915

Protection of Lactobacillus acidophilus from bile salts in a model intestinal juice by incorporation into the inner-water phase of a W/O/W emulsion

916

Protection of Lactobacillus acidophilus from the low pH of a model gastric juice by incorporation in a W/O/W emulsion

917

Protection of lactoperoxidase activity with sugars during lyophilization and evaluation of its antibacterial properties

918

Protection of LHD coils by intelligent observation of voltage signals

919

Protection of liposomes against triton X-100 by means of the new exopolymer excreted by Pseudoalteromonas antarctica NF3

920

Protection of l-methionine against H2O2-induced oxidative damage in mitochondria

921

Protection of low density lipoprotein oxidation by the antioxidant agent IRFI005, a new synthetic hydrophilic vitamin E analogue

922

Protection of lung fibroblast MRC-5 cells against hydrogen peroxide-induced oxidative damage by 0.1–2.8 kDa antioxidative peptides isolated from whey protein hydrolysate

923

Protection of Macrobrachium rosenbergii against white tail disease by oral administration of bacterial expressed and encapsulated double-stranded RNA

924

Protection of marine resources: the US Oil Pollution Act of 1990 and the future of the maritime industry

925

Protection of membrane cholesterol by sphingomyelin against free radical-mediated oxidation

926

Protection of mice against Chlamydophila abortus infection with a bacteriophage-mediated DNA vaccine expressing the major outer membrane protein

927

Protection of mice against Chlamydophila abortus infection with a bacteriophage-mediated DNA vaccine expressing the major outer membrane protein

928

Protection of mild steel against corrosion by polynitroaniline films

929

Protection of mild steel in 3 M HCl solution by Areca root extract: development of green and sustainable corrosion inhibitor

930

Protection of minority shareholder interests, cross-listings in the United States, and subsequent equity offerings

931

Protection of molecular changes in cardiac Na+-K+ ATPase and Na+-Ca2+ exchanger by preconditioning

932

Protection of myocardium by cyclosporin a and insulin: in vitro simulated ischemia study in human myocardium

933

Protection of nano-powders by adsorbed surfactants: A Monte Carlo study

934

PROTECTION OF NAVAL SYSTEMS AGAINST ELECTROMAGNETIC EFFECTS DUE TO LIGHTNING

935

Protection of Nd2Fe14B-based melt-spun ribbons using nanoscale sol–gel derived films of SiO2 and Al2O3

936

Protection of neonatal rat heart: Ischemic preconditioning and chronic hypoxia

937

Protection of nicotinic acid against oxidative stress-induced cell death in hepatocytes contributes to its beneficial effect on alcohol-induced liver injury in mice

938

Protection of NiO nanoparticles against leaching in acid medium by grafting of polyacrylic acid

939

Protection of non-human biota against radiation in freshwater—Effect of time dependence in tiered exposure assessment

940

Protection of non-human biota against radiation in freshwater—Effect of time dependence in tiered exposure assessment

941

Protection of nuclear graphite toward fluoride molten salt by glassy carbon deposit

942

Protection of nuclear graphite toward liquid fluoride salt by isotropic pyrolytic carbon coating

943

Protection of oligodeoxynucleotides against nuclease degradation through association with self-assembling peptides

944

Protection of olive planting stocks against parasitism of root-knot nematodes by arbuscular mycorrhizal fungi

945

Protection of organic matter by mineral matrix in a Cenomanian black shale

946

Protection of ornamental gold fish Carassius auratus against Aeromonas hydrophila by treating Ixora coccinea active principles

947

Protection Of Oxidative Hemolysis By Demethyldiisoeugenol In Normal and β-Thalassemic Red Blood Cells

948

Protection of Parallel Transmission Lines Using Wavelet Transform

949

Protection of PC12 cells by glutathione peroxidase in L-DOPA induced cytotoxicity

950

Protection of PC12 cells from chemical ischemia induced oxidative stress by Fagonia arabica

951

Protection of Penaeus monodon against white spot syndrome virus by inactivated vaccine with herbal immunostimulants

952

Protection of Penaeus monodon against white spot syndrome virus using a WSSV subunit vaccine

953

PROTECTION OF PERSONAL DATA: EXAMPLE OF GEOGRAPHIC INFORMATION SYSTEMS

954

Protection of phenylpropanoid metabolism by prior heat treatment in Lycopersicon esculentum exposed to Ralstonia solanacearum

955

Protection of pigs against ‘in contact’ challenge with classical swine fever following oral or subcutaneous vaccination with a recombinant porcine adenovirus

956

Protection of Places with The UN Flag (UN Premises) During Armed Conflicts in The Framework of the Contrast Between International Humanitarian Law And UN Regulations

957

Protection of plant-related innovations: Evolution and current discussion

958

Protection of Plants Against Air Pollutants: Role of Chemical Protectants

959

Protection of Plasma Membrane K+ Transport by the Salt Overly Sensitive1 Na+-H+ Antiporter during Salinity Stress

960

Protection of plasma membrane of onion epidermal cells by glycinebetaine and proline against NaCl stress

961

Protection of polynucleotides against nuclease-mediated hydrolysis by complexation with schizophyllan

962

Protection of polyunsaturated fatty acids of fish oil from common Kilka (Clupeonella cultriventris caspia) using holy basil (Ocimum sanctum) essential oil

963

Protection of polyunsaturated oils against ruminal biohydrogenation and oxidation during storage using a polyphenol oxidase containing extract from red clover

964

Protection of poorly nucleophilic pyrroles

965

Protection of Porcine Oocytes Against Cell Damage Caused by Oxidative Stress During In Vitro Maturation: Role of Superoxide Dismutase Activity in Porcine Follicular Fluid

966

Protection of Prisoners of War from Torture with Proper Selection of Soldiers Taking Care of POWs: An Ethical View

967

Protection of Procambarus clarkii against white spot syndrome virus using inactivated WSSV

968

Protection of Procambarus clarkii against white spot syndrome virus using recombinant oral vaccine expressed in Pichia pastoris

969

Protection of radiation-induced protein damage by curcumin Original Research Article

970

Protection of Rafflesia through the Appreciation of the Dusun’s Indigenous Knowledge; A Preliminary Case Study at Poring-Sabah

971

Protection of rats from thioacetamide-induced hepatic fibrosis by the extracts of a traditional Uighur medicine Cichorium glandulosum

972

Protection of renal damage by HMG-CoA inhibitors: A comparative study between atorvastatin and rosuvastatin

973

Protection of Renal Tubular Cells by Antioxidants: Current Knowledge and New Trends

974

Protection of renal tubules against gentamicin induced nephrotoxicity

975

Protection of retrovirus-induced disease by transplantation of bone marrow cells transduced with MuLV env gene via retrovirus vector

976

PROTECTION OF RIGHT OF ASYLUM

977

Protection of right pneumonectomy bronchial sutures with a pedicled thymus flap

978

Protection of Safety, Health and Welfare of Employees at Workplace Under Islamic Law

979

Protection of short-time enamel erosion by different tetrafluoride compounds

980

Protection of shrimp (Penaeus chinensis) against white spot syndrome virus (WSSV) challenge by double-stranded RNA

981

Protection of silicon nitride ceramics against corrosion in acidic aqueous solutions by enforced internal passivation

982

Protection of silver surfaces against tarnishing by means of alumina/titania-nanolayers

983

Protection of simple series and parallel systems with components of different values

984

Protection of simple series and parallel systems with components of different values

985

Protection of skin grafts to the penile shaft using a novel manipulation of Allevyn™ dressing—Case report of an alkali burn

986

Protection of soil carbon by microaggregates within earthworm casts

987

Protection of soil carbon by microaggregates within earthworm casts

988

Protection of sound enamel and artificial enamel lesions against demineralisation: Caries infiltrant versus adhesive

989

Protection of sound enamel and artificial enamel lesions against demineralisation: Caries infiltrant versus adhesive

990

Protection of southern pine from fungal decay and termite damage with N,N-naphthaloylhydroxylamine

991

Protection of starch in barley against rumen degradation by glutaraldehyde and formaldehyde as assessed by the dacron bag technique

992

Protection of storage rings and ion-beam devices from melting

993

Protection of storage rings and ion-beam devices from melting

994

Protection of Taxpayers Data and Tax Privacy

995

Protection of the AZ31 magnesium alloy with cerium modified silane coatings

996

Protection of the carbonyl groups in 1,2-indanedione: propellane versus acetal formation

997

Protection of the chronic hypoxic immature rat heart during global ischemia

998

Protection of the coelacanth, a primitive fish in the coastal waters of Tanzania

999

Protection of the containment of the twin BWR KRB II plant against overpressure failure during severe accidents Original Research Article

1000

Protection of the environment by using innovative greening technologies in land transport

بازگشت